FilingIndex
6-KThe Wire

TAKEDA PHARMACEUTICAL CO LTD files 6-K

Filed Jun 24, 2026 · 9d ago · Accession 0001395064-26-000185

Plain English

Takeda Pharmaceutical Company Limited filed its 2026 Annual Integrated Report, which includes financial information for the fiscal year ended March 31, 2026. The report details the company's financial performance and operational highlights.

Read the original on SEC.gov ↗
Filing details
Ticker
TAK
CIK
1395064
Form type
6-K
Filing date
Jun 24, 2026
Report date
Jun 24, 2026
Document
form6k-3_062426.htm
Size
10.3 MB